Skip to main content
Top
Published in: Journal of Radiation Oncology 1/2016

01-03-2016 | Original Research

A study of the factors affecting radiation-induced temporomandibular joint changes in post-radiotherapy nasopharyngeal carcinoma patients

Authors: Vincent W. C. Wu, Michael T. C. Ying, S. Y. Tam, Dora L. W. Kwong

Published in: Journal of Radiation Oncology | Issue 1/2016

Login to get access

Abstract

Background

Radiotherapy of nasopharyngeal carcinoma (NPC) often delivers considerable radiation dose to the temporomandibular joint (TMJ). This may lead to radiation-induced trismus, which can have impact on the quality of life of post-radiotherapy (post-RT) patients. However, the exact cause of trismus and its relationship with dose has not been fully understood. This study aimed to evaluate the quantitative relationship between severity of post-RT trismus and TMJ doses and other patient characteristics. Through ultrasound examination, this study also aimed to identify factors affecting morphological changes of TMJ.

Methods

Ninety-seven NPC patients treated by radiotherapy for more than 4 years were recruited. The doses to both sides of the TMJ were calculated from the treatment planning system. The severity of trismus was assessed by measuring the maximum inter-incisal distance (MID) with a caliper. Ultrasonography examination of the both sides of TMJ was performed in both transverse and longitudinal directions. For the scan of each TMJ, the MID, irregularity of mandibular condyle and the echogenicity of the joint disc ligament and pterygoid muscles were assessed.

Results

The median age of all the subjects was 56 years, with median post-RT duration of 14 years and median mean TMJ dose of 64.15 Gy. The MID (median, 3.7 cm, range, 1.3–5.2 cm) demonstrated strong negative correlations with post-RT duration (r p = −0.441, p < 0.0005) and mean doses to the TMJ (r p = −0.262, p = 0.009). The negative relationship between TMJ dose and maximum disc thickness (MDT) was also found in transverse scan (r p = −0.218, p = 0.002). However, there is no significant relationship between TMJ dose and MDT in longitudinal scan, irregularity of condyle and echogenicity of pterygoid muscle.

Conclusion

In post-RT NPC patients, the severity of trismus, expressed in MID, increased with the doses to the TMJ and post-RT duration. In addition, the joint disc thickness decreased with increased dose to TMJ. Keeping a reasonably low TMJ dose in treatment planning and longer-term monitoring of the trismus of post-RT NPC patients are suggested to ensure their quality of life.
Literature
1.
go back to reference Chen YY, Zhao C, Wang J, Ma HL, Lai SZ, Liu Y et al (2011) Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma. Cancer 117:2910–6CrossRefPubMed Chen YY, Zhao C, Wang J, Ma HL, Lai SZ, Liu Y et al (2011) Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma. Cancer 117:2910–6CrossRefPubMed
2.
go back to reference Dijkstra PU, Huisman PM, Roodenburg JLN (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–42CrossRefPubMed Dijkstra PU, Huisman PM, Roodenburg JLN (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–42CrossRefPubMed
3.
go back to reference Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A (2012) Prediction of post-treatment trismus in head and neck cancer patients. Brit J Oral Max Surg 50:328–32CrossRef Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A (2012) Prediction of post-treatment trismus in head and neck cancer patients. Brit J Oral Max Surg 50:328–32CrossRef
4.
go back to reference Nguyen TD, Panis X, Froissart D, Legros M, Coninx P, Loirette M (1988) Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int J Radiat Oncol Biol Phys 14:23–5CrossRefPubMed Nguyen TD, Panis X, Froissart D, Legros M, Coninx P, Loirette M (1988) Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers. Int J Radiat Oncol Biol Phys 14:23–5CrossRefPubMed
5.
go back to reference Jen YM, Lin YS, Su WF, Hsu WL, Hwang JM, Chao HL et al (2002) Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending? Int J Radiat Oncol Biol Phys 54:14–22CrossRefPubMed Jen YM, Lin YS, Su WF, Hsu WL, Hwang JM, Chao HL et al (2002) Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending? Int J Radiat Oncol Biol Phys 54:14–22CrossRefPubMed
6.
go back to reference Scott B, Butterworth C, Lowe D, Rogers SN (2008) Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol 44:430–8CrossRefPubMed Scott B, Butterworth C, Lowe D, Rogers SN (2008) Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol 44:430–8CrossRefPubMed
7.
go back to reference Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT et al (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18(8):1033–8CrossRefPubMed Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT et al (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18(8):1033–8CrossRefPubMed
8.
go back to reference Caria N, Setton J, Zhang Z, Romanyshyn J, Hsu M, Branski RC et al (2010) Dosimetric correlation of the muscles of mastication with trismus in patients undergoing intensity modulated radiotherapy (IMRT) and chemotherapy for oropharyngeal carcinoma (OPC). Int J Radiat Oncol Biol Phys 78(3):S427CrossRef Caria N, Setton J, Zhang Z, Romanyshyn J, Hsu M, Branski RC et al (2010) Dosimetric correlation of the muscles of mastication with trismus in patients undergoing intensity modulated radiotherapy (IMRT) and chemotherapy for oropharyngeal carcinoma (OPC). Int J Radiat Oncol Biol Phys 78(3):S427CrossRef
9.
go back to reference van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR et al (2013) Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol 106:364–9CrossRefPubMed van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR et al (2013) Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol 106:364–9CrossRefPubMed
10.
go back to reference Hsiung CY, Huang EY, Ting HM, Huang HY (2008) Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 81(970):809–14CrossRefPubMed Hsiung CY, Huang EY, Ting HM, Huang HY (2008) Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 81(970):809–14CrossRefPubMed
12.
go back to reference Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115(8):1458–60CrossRefPubMed Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115(8):1458–60CrossRefPubMed
13.
go back to reference Sun X, Su S, Chen C, Han F, Zhao C, Xiao W et al (2014) Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol 110(3):398–403CrossRefPubMed Sun X, Su S, Chen C, Han F, Zhao C, Xiao W et al (2014) Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol 110(3):398–403CrossRefPubMed
14.
go back to reference Kaplan AS, Assael LA (1991) Temporomandibular disorders: diagnosis and treatment, 1st edn. W.B. Saunders, Philadelphia Kaplan AS, Assael LA (1991) Temporomandibular disorders: diagnosis and treatment, 1st edn. W.B. Saunders, Philadelphia
15.
go back to reference Saintigny Y, Cruet-Hennequart S, Hamdi DH, Chevalier F, Lefaix JL (2015) Impact of therapeutic irradiation on healthy articular cartilage. Radiat Res 183(2):135–146CrossRefPubMed Saintigny Y, Cruet-Hennequart S, Hamdi DH, Chevalier F, Lefaix JL (2015) Impact of therapeutic irradiation on healthy articular cartilage. Radiat Res 183(2):135–146CrossRefPubMed
16.
go back to reference Tolentino EDS, Centurion BS, Ferreira LHC, de Souza AP, Damante JH, Rubira-Bullen IRF (2011) Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 19(5):448–54CrossRefPubMedCentral Tolentino EDS, Centurion BS, Ferreira LHC, de Souza AP, Damante JH, Rubira-Bullen IRF (2011) Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci 19(5):448–54CrossRefPubMedCentral
17.
go back to reference Manfredini D, Guarda-Nardini L (2009) Ultrasonography of the temporomandibular joint: a literature review. Int J Oral Maxillofac Surg 38:1229–36CrossRefPubMed Manfredini D, Guarda-Nardini L (2009) Ultrasonography of the temporomandibular joint: a literature review. Int J Oral Maxillofac Surg 38:1229–36CrossRefPubMed
Metadata
Title
A study of the factors affecting radiation-induced temporomandibular joint changes in post-radiotherapy nasopharyngeal carcinoma patients
Authors
Vincent W. C. Wu
Michael T. C. Ying
S. Y. Tam
Dora L. W. Kwong
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 1/2016
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-015-0215-6

Other articles of this Issue 1/2016

Journal of Radiation Oncology 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine